Tadanobu Yoshikawa
Tadanobu Yoshikawa has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
Kimie Miyata
Department of Ophthalmology, Nara Medical University, Kashihara, Nara, Japan
10 shared publicationsNahoko Ogata
Department of Ophthalmology, Nara Medical University, Kashihara, Nara, Japan
10 shared publicationsKeigo Saeki
Department of Epidemiology, Nara Medical University, Kashihara, Nara, Japan
8 shared publications- Kenji Obayashi
Nara Medical University School of Medicine
6 shared publications Kenji Obayashi
Epidemiology, Nara Medical University School of Medicine, Nara
5 shared publicationsHironobu Jimura
Department of Ophthalmology, Nara Medical University, Kashihara, Nara, Japan
4 shared publications
Latest Publications
- 21 August 2026
- Published by BMJ in British Journal of Ophthalmology
Sleep disturbance and incident depressive symptoms in patients with glaucoma: a longitudinal study of the LIGHT cohort
Aims: To investigate whether baseline sleep disturbance is associated with an increased risk of incident depressive symptoms in patients with glaucoma. Methods: In our prospective cohort study, a total of 120 patients with glaucoma who had no depressive symptoms at baseline (mean age 70.1 years) were included. Depressive symptoms, defined as a Geriatric Depression Scale score of 6 or greater, were assessed at baseline and at annual follow-up visits. Sleep disturbance was defined as a Pittsburgh Sleep Quality Index score of 6 or greater. Results: During a median follow-up of 3.94 years, 29 of 120 patients developed depressive symptoms. Kaplan-Meier analysis with the log-rank test showed a higher cumulative incidence of depressive symptoms in the group with baseline sleep disturbance than in the group without sleep disturbance (p=0.021). In Cox proportional hazards models, sleep disturbance was associated with an increased risk of incident depressive symptoms (HR 2.32; 95% CI 1.11 to 4.83). Results remained consistent after adjustment for potential confounders, including visual acuity (HR 3.03; 95% CI 1.25 to 7.33). A significant interaction was observed between sleep disturbance and glaucoma severity in relation to incident depressive symptoms (p=0.021). An association between sleep disturbance and incident depressive symptoms was observed in the non-severe glaucoma group (p<0.001), whereas no significant association was found in the severe glaucoma group. Conclusions: Baseline sleep disturbance was independently associated with a higher risk of incident depressive symptoms in patients with glaucoma, irrespective of visual impairment.
- 21 August 2026
- Published by BMJ in British Journal of Ophthalmology
Sleep disturbance and incident depressive symptoms in patients with glaucoma: a longitudinal study of the LIGHT cohort
Aims: To investigate whether baseline sleep disturbance is associated with an increased risk of incident depressive symptoms in patients with glaucoma. Methods: In our prospective cohort study, a total of 120 patients with glaucoma who had no depressive symptoms at baseline (mean age 70.1 years) were included. Depressive symptoms, defined as a Geriatric Depression Scale score of 6 or greater, were assessed at baseline and at annual follow-up visits. Sleep disturbance was defined as a Pittsburgh Sleep Quality Index score of 6 or greater. Results: During a median follow-up of 3.94 years, 29 of 120 patients developed depressive symptoms. Kaplan-Meier analysis with the log-rank test showed a higher cumulative incidence of depressive symptoms in the group with baseline sleep disturbance than in the group without sleep disturbance (p=0.021). In Cox proportional hazards models, sleep disturbance was associated with an increased risk of incident depressive symptoms (HR 2.32; 95% CI 1.11 to 4.83). Results remained consistent after adjustment for potential confounders, including visual acuity (HR 3.03; 95% CI 1.25 to 7.33). A significant interaction was observed between sleep disturbance and glaucoma severity in relation to incident depressive symptoms (p=0.021). An association between sleep disturbance and incident depressive symptoms was observed in the non-severe glaucoma group (p<0.001), whereas no significant association was found in the severe glaucoma group. Conclusions: Baseline sleep disturbance was independently associated with a higher risk of incident depressive symptoms in patients with glaucoma, irrespective of visual impairment.
- 22 December 2025
- Published by Wolters Kluwer Health in Journal of Glaucoma
- Vol. 35 (5) , 348-352
Reduced Optic Nerve Head Blood Flow Correlates With an Impaired Postillumination Pupil Response in Glaucoma
Précis: In glaucomatous eyes, reduced optic nerve head blood flow was significantly associated with impaired intrinsically photosensitive retinal ganglion cell function, as assessed by the postillumination pupil response, independent of age and other confounding factors. Purpose: To investigate whether ocular nerve head (ONH) blood flow is associated with impaired intrinsically photosensitive retinal ganglion cell (ipRGC) function, assessed by the postillumination pupil response (PIPR), in eyes with glaucoma. Patients and Methods: This cross-sectional study included 114 eyes from 114 patients with glaucoma (mean age, 69.5 y). PIPR was evaluated by measuring pupil diameters after red and blue light exposure. The main PIPR outcomes were the amplitudes of red and blue 6-second PIPR, which are pupil diameters 6 seconds after red and blue light exposure. ONH blood flow was assessed by the tissue-area mean blur rate (MBR) using laser speckle flowgraphy. Results: A significantly higher blue 6-second PIPR amplitude was observed in the low tissue-area MBR group than in the high tissue-area MBR group (93.5% vs. 91.1%, P =0.043). After adjusting for age, sex, body mass index, hypertension, diabetes, intraocular pressure, and axial length, a multivariable linear regression analysis showed that tissue-area MBR inversely correlated with the blue 6-second PIPR amplitude (regression coefficient=−0.40; 95% CI, −0.73 to −0.06; P =0.021), but not the red 6-second PIPR amplitude (regression coefficient=−0.01; 95% CI, −0.36 to −0.15; P =0.42). Conclusions: Lower ONH blood flow in eyes with glaucoma correlated with impairments in ipRGCs independent of potential confounders, including age.
- 22 December 2025
- Published by Wolters Kluwer Health in Journal of Glaucoma
- Vol. 35 (5) , 348-352
Reduced Optic Nerve Head Blood Flow Correlates With an Impaired Postillumination Pupil Response in Glaucoma
Précis: In glaucomatous eyes, reduced optic nerve head blood flow was significantly associated with impaired intrinsically photosensitive retinal ganglion cell function, as assessed by the postillumination pupil response, independent of age and other confounding factors. Purpose: To investigate whether ocular nerve head (ONH) blood flow is associated with impaired intrinsically photosensitive retinal ganglion cell (ipRGC) function, assessed by the postillumination pupil response (PIPR), in eyes with glaucoma. Patients and Methods: This cross-sectional study included 114 eyes from 114 patients with glaucoma (mean age, 69.5 y). PIPR was evaluated by measuring pupil diameters after red and blue light exposure. The main PIPR outcomes were the amplitudes of red and blue 6-second PIPR, which are pupil diameters 6 seconds after red and blue light exposure. ONH blood flow was assessed by the tissue-area mean blur rate (MBR) using laser speckle flowgraphy. Results: A significantly higher blue 6-second PIPR amplitude was observed in the low tissue-area MBR group than in the high tissue-area MBR group (93.5% vs. 91.1%, P =0.043). After adjusting for age, sex, body mass index, hypertension, diabetes, intraocular pressure, and axial length, a multivariable linear regression analysis showed that tissue-area MBR inversely correlated with the blue 6-second PIPR amplitude (regression coefficient=−0.40; 95% CI, −0.73 to −0.06; P =0.021), but not the red 6-second PIPR amplitude (regression coefficient=−0.01; 95% CI, −0.36 to −0.15; P =0.42). Conclusions: Lower ONH blood flow in eyes with glaucoma correlated with impairments in ipRGCs independent of potential confounders, including age.
- Open Access
- 8 February 2024
- Published by Oxford University Press (OUP) in SLEEP
- Vol. 47 (8)
Daily light exposure profiles and the association with objective sleep quality in patients with Parkinson’s disease: The PHASE study
Study Objectives: Light information crucially influences sleep initiation and continuity. The purpose of this study was to compare daily light exposure between patients with Parkinson’s disease (PD) and non-PD older adults and evaluate the association of daily light exposure with objective sleep measures in patients with PD. Methods: In this cross-sectional study of 189 outpatients with PD and 1101 community-dwelling older adults (controls), daily light exposure was measured using wrist light meters during the daytime and light meters set in the bedrooms during the nighttime, and objective sleep quality was measured by wrist actigraphy. Results: The median duration of exposure to ≥ 1000 lux light was significantly shorter in patients with PD than in controls. The median nighttime light intensity was higher in patients with PD than in controls. Among patients with PD, multivariable analysis suggested that the highest quartile of exposure to ≥ 1000 lux light during the daytime was linked to significantly higher sleep efficiency (SE) by 8.0% and shorter wake after sleep onset (WASO) by 36.9 minutes than the lowest quartile. During the nighttime, the highest quartile of mean light intensity had significantly lower SE by 6.8%, longer WASO by 24.1 minutes, longer sleep onset latency, and higher fragmentation index, than the lowest quartile. Importantly, daytime and nighttime light levels were independently associated with objective sleep measures. Conclusions: The present study illustrated that greater daytime light exposure and lower nighttime light exposure are significantly associated with better objective sleep measures in patients with PD.
- 8 February 2024
- Published by Oxford University Press (OUP) in SLEEP
- Vol. 47 (8)
Open AccessDaily light exposure profiles and the association with objective sleep quality in patients with Parkinson’s disease: The PHASE study
Study Objectives: Light information crucially influences sleep initiation and continuity. The purpose of this study was to compare daily light exposure between patients with Parkinson’s disease (PD) and non-PD older adults and evaluate the association of daily light exposure with objective sleep measures in patients with PD. Methods: In this cross-sectional study of 189 outpatients with PD and 1101 community-dwelling older adults (controls), daily light exposure was measured using wrist light meters during the daytime and light meters set in the bedrooms during the nighttime, and objective sleep quality was measured by wrist actigraphy. Results: The median duration of exposure to ≥ 1000 lux light was significantly shorter in patients with PD than in controls. The median nighttime light intensity was higher in patients with PD than in controls. Among patients with PD, multivariable analysis suggested that the highest quartile of exposure to ≥ 1000 lux light during the daytime was linked to significantly higher sleep efficiency (SE) by 8.0% and shorter wake after sleep onset (WASO) by 36.9 minutes than the lowest quartile. During the nighttime, the highest quartile of mean light intensity had significantly lower SE by 6.8%, longer WASO by 24.1 minutes, longer sleep onset latency, and higher fragmentation index, than the lowest quartile. Importantly, daytime and nighttime light levels were independently associated with objective sleep measures. Conclusions: The present study illustrated that greater daytime light exposure and lower nighttime light exposure are significantly associated with better objective sleep measures in patients with PD.
- Open Access
- 1 September 2023
- Published by Association for Research in Vision and Ophthalmology (ARVO) in Investigative Ophthalmology & Visual Science
- Vol. 64 (12) , 34
Post-Illumination Pupil Response and Sleep Quality in Patients With Glaucoma: The LIGHT Study
Purpose: This study aimed to investigate whether intrinsically photosensitive retinal ganglion cell function evaluated using post-illumination pupil response (PIPR) in patients with glaucoma is associated with sleep quality. Methods: This cross-sectional study measured the PIPR in 138 patients with glaucoma (mean age, 70.3 years) using pupil diameter after red and blue light exposure. The net PIPR change was classified into three groups according to tertiles (i.e., low, intermediate, and high groups), with lower net PIPR change indicating lower intrinsically photosensitive retinal ganglion cell (ipRGC) function. Subjective and objective sleep qualities were assessed using the Pittsburgh Sleep Quality Index (PSQI) questionnaire and actigraphy, respectively, with a total PSQI score of ≥6 indicating sleep disturbance. Results: The prevalence of subjective sleep disturbance significantly increased with decreasing tertile groups of net PIPR change (P = 0.036). Subgroup analysis obtained the same results in the severe glaucoma group (P = 0.004) but not in the non-severe glaucoma group. In the severe glaucoma group, multivariable logistic regression analysis adjusted for potential confounders showed a higher odds ratio for subjective sleep disturbance in the low-tertile group of net PIPR compared with the high-tertile group (odds ratio = 6.22; 95% confidence interval, 1.76–21.90; P = 0.004). Significant associations between PIPR and objective sleep quality (total sleep time, sleep efficiency, and wake after sleep onset) were found in the severe glaucoma group (P = 0.015, P = 0.013, and P = 0.015, respectively). Conclusions: The PIPR in patients with glaucoma was significantly associated with decreased sleep quality, independent of potential confounders.
- 1 September 2023
- Published by Association for Research in Vision and Ophthalmology (ARVO) in Investigative Ophthalmology & Visual Science
- Vol. 64 (12) , 34
Open AccessPost-Illumination Pupil Response and Sleep Quality in Patients With Glaucoma: The LIGHT Study
Purpose: This study aimed to investigate whether intrinsically photosensitive retinal ganglion cell function evaluated using post-illumination pupil response (PIPR) in patients with glaucoma is associated with sleep quality. Methods: This cross-sectional study measured the PIPR in 138 patients with glaucoma (mean age, 70.3 years) using pupil diameter after red and blue light exposure. The net PIPR change was classified into three groups according to tertiles (i.e., low, intermediate, and high groups), with lower net PIPR change indicating lower intrinsically photosensitive retinal ganglion cell (ipRGC) function. Subjective and objective sleep qualities were assessed using the Pittsburgh Sleep Quality Index (PSQI) questionnaire and actigraphy, respectively, with a total PSQI score of ≥6 indicating sleep disturbance. Results: The prevalence of subjective sleep disturbance significantly increased with decreasing tertile groups of net PIPR change (P = 0.036). Subgroup analysis obtained the same results in the severe glaucoma group (P = 0.004) but not in the non-severe glaucoma group. In the severe glaucoma group, multivariable logistic regression analysis adjusted for potential confounders showed a higher odds ratio for subjective sleep disturbance in the low-tertile group of net PIPR compared with the high-tertile group (odds ratio = 6.22; 95% confidence interval, 1.76–21.90; P = 0.004). Significant associations between PIPR and objective sleep quality (total sleep time, sleep efficiency, and wake after sleep onset) were found in the severe glaucoma group (P = 0.015, P = 0.013, and P = 0.015, respectively). Conclusions: The PIPR in patients with glaucoma was significantly associated with decreased sleep quality, independent of potential confounders.
- 4 April 2023
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 41 (6) , 1018-1023
Circadian blood pressure variability and asymmetric dimethylarginine in patients with glaucoma: cross-sectional study of The LIGHT cohort
Objective: Glaucoma is reportedly associated with asymmetric dimethylarginine (ADMA) and circadian blood pressure (BP) variability, including night-time SBP. We determined whether ADMA level is associated with night-time SBP in patients with glaucoma. Methods: In this cross-sectional study, we measured the serum ADMA level and ambulatory BP of 163 patients with glaucoma and 705 participants without glaucoma. Based on the tertiles of serum ADMA level, the patients were divided into three groups: low, intermediate, and high-ADMA. Night-time SBP was determined based on ambulatory BP measured every 30 min for 48 h. The nondipper BP pattern was defined as having a night-time mean SBP decline of less than 10% relative to the mean daytime SBP. Results: In the glaucoma group, the night-time SBP in the high-ADMA group was significantly higher than in the low-ADMA group (123.0 and 114.4 mmHg, respectively; P = 0.003). Multivariable analysis adjusted for the potential confounders showed the night-time SBP, and the odds ratio for nondipper in the high-ADMA group were also significantly higher than in the low-ADMA group (P = 0.030 and P = 0.021, respectively). Significant associations between continuous serum ADMA levels with night-time SBP and nondipper were also found (P = 0.002 and 0.006, respectively). In the control group, however, no significant associations were found between serum ADMA levels and night-time SBP and nondipper. A significant interaction effect of the serum ADMA levels and glaucoma on nondipper was found (P = 0.004). Conclusion: Serum ADMA level was significantly associated with the disturbance of circadian BP variability in patients with glaucoma.
- 4 April 2023
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 41 (6) , 1018-1023
Circadian blood pressure variability and asymmetric dimethylarginine in patients with glaucoma: cross-sectional study of The LIGHT cohort
Objective: Glaucoma is reportedly associated with asymmetric dimethylarginine (ADMA) and circadian blood pressure (BP) variability, including night-time SBP. We determined whether ADMA level is associated with night-time SBP in patients with glaucoma. Methods: In this cross-sectional study, we measured the serum ADMA level and ambulatory BP of 163 patients with glaucoma and 705 participants without glaucoma. Based on the tertiles of serum ADMA level, the patients were divided into three groups: low, intermediate, and high-ADMA. Night-time SBP was determined based on ambulatory BP measured every 30 min for 48 h. The nondipper BP pattern was defined as having a night-time mean SBP decline of less than 10% relative to the mean daytime SBP. Results: In the glaucoma group, the night-time SBP in the high-ADMA group was significantly higher than in the low-ADMA group (123.0 and 114.4 mmHg, respectively; P = 0.003). Multivariable analysis adjusted for the potential confounders showed the night-time SBP, and the odds ratio for nondipper in the high-ADMA group were also significantly higher than in the low-ADMA group (P = 0.030 and P = 0.021, respectively). Significant associations between continuous serum ADMA levels with night-time SBP and nondipper were also found (P = 0.002 and 0.006, respectively). In the control group, however, no significant associations were found between serum ADMA levels and night-time SBP and nondipper. A significant interaction effect of the serum ADMA levels and glaucoma on nondipper was found (P = 0.004). Conclusion: Serum ADMA level was significantly associated with the disturbance of circadian BP variability in patients with glaucoma.
- Open Access
- 2 March 2022
- Published by Association for Research in Vision and Ophthalmology (ARVO) in Investigative Ophthalmology & Visual Science
- Vol. 63 (3) , 24
Association Between Postillumination Pupil Response and Glaucoma Severity: A Cross-Sectional Analysis of the LIGHT Study
Purpose: This study determines whether the functional and structural severity of glaucoma is associated with intrinsically photosensitive retinal ganglion cell (ipRGC) function. Methods: This cross-sectional study assessed 148 eyes from 148 patients with glaucoma (mean age 70.5 years). The ipRGC function was assessed by postillumination pupil response (PIPR) using the pupil diameter after exposure to blue and red light. Main outcome measures were as follows: six-second PIPR amplitude, net PIPR, and net PIPR change. Functional and structural glaucoma severities were evaluated using visual field mean deviation (MD) and the circumpapillary retinal nerve fiber layer (RNFL) thickness, respectively. Results: Multivariable analysis adjusting for age, sex, body mass index, hypertension, diabetes, oral medication use, cataract surgery, axial length, and topical alpha2-adrenergic receptor agonist use showed that worsening in visual field MD was significantly associated with higher blue six-second PIPR amplitude (regression coefficient per −1 dB worsening, 0.25; 95% confidence intervals [CI], 0.14, 0.37; P < 0.001). The thinner RNFL thickness was significantly associated with higher blue six-second PIPR amplitude, lower Net PIPR change, and lower net PIPR (blue six-second PIPR amplitude: regression coefficient per 10-µm thinning, 1.29; 95% CI, 0.72, 1.87; P < 0.001; net PIPR change: regression coefficient, −0.70; 95% CI, −1.26, −0.14; P = 0.015; net PIPR: regression coefficient, −0.03; 95% CI, −0.05, −0.001; P = 0.044). No significant association was found between glaucoma severity and red six-second PIPR amplitude. Conclusions: Our findings revealed a significant association between functional and structural glaucoma severity and impaired ipRGC function independent of potential confounders.
- 2 March 2022
- Published by Association for Research in Vision and Ophthalmology (ARVO) in Investigative Ophthalmology & Visual Science
- Vol. 63 (3) , 24
Open AccessAssociation Between Postillumination Pupil Response and Glaucoma Severity: A Cross-Sectional Analysis of the LIGHT Study
Purpose: This study determines whether the functional and structural severity of glaucoma is associated with intrinsically photosensitive retinal ganglion cell (ipRGC) function. Methods: This cross-sectional study assessed 148 eyes from 148 patients with glaucoma (mean age 70.5 years). The ipRGC function was assessed by postillumination pupil response (PIPR) using the pupil diameter after exposure to blue and red light. Main outcome measures were as follows: six-second PIPR amplitude, net PIPR, and net PIPR change. Functional and structural glaucoma severities were evaluated using visual field mean deviation (MD) and the circumpapillary retinal nerve fiber layer (RNFL) thickness, respectively. Results: Multivariable analysis adjusting for age, sex, body mass index, hypertension, diabetes, oral medication use, cataract surgery, axial length, and topical alpha2-adrenergic receptor agonist use showed that worsening in visual field MD was significantly associated with higher blue six-second PIPR amplitude (regression coefficient per −1 dB worsening, 0.25; 95% confidence intervals [CI], 0.14, 0.37; P < 0.001). The thinner RNFL thickness was significantly associated with higher blue six-second PIPR amplitude, lower Net PIPR change, and lower net PIPR (blue six-second PIPR amplitude: regression coefficient per 10-µm thinning, 1.29; 95% CI, 0.72, 1.87; P < 0.001; net PIPR change: regression coefficient, −0.70; 95% CI, −1.26, −0.14; P = 0.015; net PIPR: regression coefficient, −0.03; 95% CI, −0.05, −0.001; P = 0.044). No significant association was found between glaucoma severity and red six-second PIPR amplitude. Conclusions: Our findings revealed a significant association between functional and structural glaucoma severity and impaired ipRGC function independent of potential confounders.
- Open Access
- 12 August 2021
- Published by Wolters Kluwer Health in Journal of Glaucoma
- Vol. 30 (10) , 882-886
Lower Cognitive Function in Patients With Functionally and Structurally Severe Glaucoma: The LIGHT Study
Precis: This cross-sectional study of 172 patients with glaucoma showed that functional and structural glaucoma damage was significantly associated with cognitive impairment independent of age and visual acuity. Purpose: The aim of this study was to determine whether functional and structural glaucoma damage is associated with cognitive function. Patients and Methods: This was a cross-sectional analysis comprising 172 patients with glaucoma with a mean age of 70.6 years. Functional glaucoma severity was evaluated according to the visual field mean deviation (MD) (severe, MD ≤−12 dB; mild, MD >−12 dB), and structural glaucoma severity was determined based on circumpapillary retinal nerve fiber layer thickness. The main outcome measure was cognitive impairment defined by a Mini-Mental State Examination (MMSE) score of ≤26 and MMSE-blind score of ≤16. Results: The prevalence of patients with cognitive impairment (MMSE score ≤26) was significantly higher in the severe glaucoma group than in the mild glaucoma group (33.3% vs. 15.7%; P=0.010, respectively). Similar results were obtained in the analyses with MMSE-blind score of ≤16 (14.7% vs. 1.4%; P=0.003, respectively). Multivariable logistic regression analysis adjusted for potential confounders, including age, body mass index, education, visual acuity, hypertension, diabetes, and depressive symptoms, indicated a higher odds ratio (OR) for cognitive impairment (MMSE score ≤26) in patients with severe glaucoma than in those with mild glaucoma (OR, 2.62; 95% confidence interval, 1.006-6.84; P=0.049) and in relation to a 10-μm thinning of the retinal nerve fiber layer (OR, 1.42; 95% confidence interval, 1.05-1.93; P=0.025). Conclusion: Functional and structural glaucoma damage was significantly associated with lower cognitive function independent of age and visual acuity in a glaucoma cohort.
- 12 August 2021
- Published by Wolters Kluwer Health in Journal of Glaucoma
- Vol. 30 (10) , 882-886
Open AccessLower Cognitive Function in Patients With Functionally and Structurally Severe Glaucoma: The LIGHT Study
Precis: This cross-sectional study of 172 patients with glaucoma showed that functional and structural glaucoma damage was significantly associated with cognitive impairment independent of age and visual acuity. Purpose: The aim of this study was to determine whether functional and structural glaucoma damage is associated with cognitive function. Patients and Methods: This was a cross-sectional analysis comprising 172 patients with glaucoma with a mean age of 70.6 years. Functional glaucoma severity was evaluated according to the visual field mean deviation (MD) (severe, MD ≤−12 dB; mild, MD >−12 dB), and structural glaucoma severity was determined based on circumpapillary retinal nerve fiber layer thickness. The main outcome measure was cognitive impairment defined by a Mini-Mental State Examination (MMSE) score of ≤26 and MMSE-blind score of ≤16. Results: The prevalence of patients with cognitive impairment (MMSE score ≤26) was significantly higher in the severe glaucoma group than in the mild glaucoma group (33.3% vs. 15.7%; P=0.010, respectively). Similar results were obtained in the analyses with MMSE-blind score of ≤16 (14.7% vs. 1.4%; P=0.003, respectively). Multivariable logistic regression analysis adjusted for potential confounders, including age, body mass index, education, visual acuity, hypertension, diabetes, and depressive symptoms, indicated a higher odds ratio (OR) for cognitive impairment (MMSE score ≤26) in patients with severe glaucoma than in those with mild glaucoma (OR, 2.62; 95% confidence interval, 1.006-6.84; P=0.049) and in relation to a 10-μm thinning of the retinal nerve fiber layer (OR, 1.42; 95% confidence interval, 1.05-1.93; P=0.025). Conclusion: Functional and structural glaucoma damage was significantly associated with lower cognitive function independent of age and visual acuity in a glaucoma cohort.
- Open Access
- 1 April 2021
- Published by Association for Research in Vision and Ophthalmology (ARVO) in Investigative Ophthalmology & Visual Science
- Vol. 62 (4) , 7
Association Between the Asymmetric Dimethylarginine Levels and Glaucoma Severity: A Cross-Sectional Analysis of the LIGHT Study
Purpose: Asymmetric dimethylarginine (ADMA), a potent endogenous inhibitor of nitric oxide synthase, may be involved in the pathophysiology of glaucoma by dysfunctioning nitric oxide and oxidative stress. The purpose of this study was to determine whether the serum ADMA level is associated with the severity of glaucoma. Methods: One hundred twenty-five patients with glaucoma (mean age 69.4 years) were analyzed in this cross-sectional study. The severity of glaucoma was determined by the visual field mean deviation in the worse eye; severe, a mean deviation ≤ −12 dB; and mild, a mean deviation > −12 dB. The serum ADMA levels were classified into three groups according to tertiles; low (T1), intermediate (T2), and high group (T3). Results: The mean serum ADMA levels in the severe glaucoma group was significantly higher than that in the mild glaucoma group (0.41 vs. 0.39 µmol/L; P = 0.031). A significantly higher prevalence of patients with severe glaucoma was found in the T3 group than that in the T1 group (T1, 44.7% and T3, 68.2%; P = 0.018). In the multivariable logistic regression analysis adjusted for the potential confounders, e.g., age, sex, obesity, smoking, hypertension, diabetes, and renal function, the odds ratio for severe glaucoma in the T3 group was significantly higher than that in the T1 group (odds ratio 3.02; 95% confidence interval 1.04 to 8.79; P = 0.043). Conclusions: A significant association between higher serum ADMA levels and severe glaucoma was found, and this association remained significant after adjusting for the potential confounders.
- 1 April 2021
- Published by Association for Research in Vision and Ophthalmology (ARVO) in Investigative Ophthalmology & Visual Science
- Vol. 62 (4) , 7
Open AccessAssociation Between the Asymmetric Dimethylarginine Levels and Glaucoma Severity: A Cross-Sectional Analysis of the LIGHT Study
Purpose: Asymmetric dimethylarginine (ADMA), a potent endogenous inhibitor of nitric oxide synthase, may be involved in the pathophysiology of glaucoma by dysfunctioning nitric oxide and oxidative stress. The purpose of this study was to determine whether the serum ADMA level is associated with the severity of glaucoma. Methods: One hundred twenty-five patients with glaucoma (mean age 69.4 years) were analyzed in this cross-sectional study. The severity of glaucoma was determined by the visual field mean deviation in the worse eye; severe, a mean deviation ≤ −12 dB; and mild, a mean deviation > −12 dB. The serum ADMA levels were classified into three groups according to tertiles; low (T1), intermediate (T2), and high group (T3). Results: The mean serum ADMA levels in the severe glaucoma group was significantly higher than that in the mild glaucoma group (0.41 vs. 0.39 µmol/L; P = 0.031). A significantly higher prevalence of patients with severe glaucoma was found in the T3 group than that in the T1 group (T1, 44.7% and T3, 68.2%; P = 0.018). In the multivariable logistic regression analysis adjusted for the potential confounders, e.g., age, sex, obesity, smoking, hypertension, diabetes, and renal function, the odds ratio for severe glaucoma in the T3 group was significantly higher than that in the T1 group (odds ratio 3.02; 95% confidence interval 1.04 to 8.79; P = 0.043). Conclusions: A significant association between higher serum ADMA levels and severe glaucoma was found, and this association remained significant after adjusting for the potential confounders.
- 1 May 2020
- Published by Elsevier in Ophthalmology
- Vol. 127 (5) , E31-E32
Re: Yoshikawa et al.: Increased nighttime blood pressure in patients with glaucoma: cross-sectional analysis of the LIGHT study (Ophthalmology. 2019;126:1366-1371) Reply
- 1 May 2020
- Published by Elsevier in Ophthalmology
- Vol. 127 (5) , E31-E32
Re: Yoshikawa et al.: Increased nighttime blood pressure in patients with glaucoma: cross-sectional analysis of the LIGHT study (Ophthalmology. 2019;126:1366-1371) Reply
- 25 April 2020
- Published by Wiley in Journal of Pineal Research
- Vol. 69 (2) , e12662
Decreased melatonin secretion in patients with glaucoma: Quantitative association with glaucoma severity in the LIGHT study
Glaucoma may be associated with circadian disruption due to its association with a loss of intrinsically photosensitive retinal ganglion cells. Clinical evidence demonstrating an association between glaucoma and circadian disruption is limited, and no large‐scale studies have been performed. The purpose of this cross‐sectional study was to determine whether the presence and severity of glaucoma is correlated with the urinary 6‐sulfatoxymelatonin levels as a circadian rhythm parameter. We measured the level of urinary 6‐sulfatoxymelatonin excretion (UME) in 118 glaucoma patients and 395 control participants without glaucoma. The UME in the glaucoma group was significantly lower than that of the control group without glaucoma (3.05 and 3.24 log ng/mg creatinine, respectively; P = .010). Next, we examined association of the severity of glaucoma and melatonin levels. In stratification analysis of the glaucoma groups, multivariable linear regression analyses adjusted for potential confounders indicated significantly lower UME by 0.30 log ng/mg creatinine in patients with functional severe glaucoma (visual field mean deviation ≤ −6 dB) compared with mild glaucoma (mean deviation > −6 dB; P = .040) and lower UME by 0.05 log ng/mg creatinine with each 10 μm thinning of the circumpapillary retinal nerve fiber layer thickness as the index of structural severity of glaucoma (P = .011). In conclusion, significant association between glaucoma and lower urinary 6‐sulfatoxymelatonin was found. In addition, patients with functional and structural severe glaucoma were significantly associated with lower urinary 6‐sulfatoxymelatonin levels. Our results indicate the possibility of a circadian disruption in patients with glaucoma.
- 25 April 2020
- Published by Wiley in Journal of Pineal Research
- Vol. 69 (2) , e12662
Decreased melatonin secretion in patients with glaucoma: Quantitative association with glaucoma severity in the LIGHT study
Glaucoma may be associated with circadian disruption due to its association with a loss of intrinsically photosensitive retinal ganglion cells. Clinical evidence demonstrating an association between glaucoma and circadian disruption is limited, and no large‐scale studies have been performed. The purpose of this cross‐sectional study was to determine whether the presence and severity of glaucoma is correlated with the urinary 6‐sulfatoxymelatonin levels as a circadian rhythm parameter. We measured the level of urinary 6‐sulfatoxymelatonin excretion (UME) in 118 glaucoma patients and 395 control participants without glaucoma. The UME in the glaucoma group was significantly lower than that of the control group without glaucoma (3.05 and 3.24 log ng/mg creatinine, respectively; P = .010). Next, we examined association of the severity of glaucoma and melatonin levels. In stratification analysis of the glaucoma groups, multivariable linear regression analyses adjusted for potential confounders indicated significantly lower UME by 0.30 log ng/mg creatinine in patients with functional severe glaucoma (visual field mean deviation ≤ −6 dB) compared with mild glaucoma (mean deviation > −6 dB; P = .040) and lower UME by 0.05 log ng/mg creatinine with each 10 μm thinning of the circumpapillary retinal nerve fiber layer thickness as the index of structural severity of glaucoma (P = .011). In conclusion, significant association between glaucoma and lower urinary 6‐sulfatoxymelatonin was found. In addition, patients with functional and structural severe glaucoma were significantly associated with lower urinary 6‐sulfatoxymelatonin levels. Our results indicate the possibility of a circadian disruption in patients with glaucoma.